(Total Views: 307)
Posted On: 09/17/2021 1:35:40 AM
Post# of 145249
Nelson et al,
I expect some of the whole virus vaccines to gain a foothold, should they prove effective in trials.
They should elector a broader range of antibodies than antibodies specific to one spike protein conformation.
There is a potential that these could be effective against infection, not just severe disease manifestations.
Leronlimab of course may very well rule the roost after successful Brazilian and LH trials.
I expect some of the whole virus vaccines to gain a foothold, should they prove effective in trials.
They should elector a broader range of antibodies than antibodies specific to one spike protein conformation.
There is a potential that these could be effective against infection, not just severe disease manifestations.
Leronlimab of course may very well rule the roost after successful Brazilian and LH trials.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)